We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.35 | 4.20 | 4.50 | 4.35 | 4.35 | 4.35 | 0.00 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.36 | 23.2M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/8/2023 11:22 | But is Eden making any contribution to that?! When was the last time we heard anything from Eden about Elanco? 29th September 2020 Half Yearly Report "An amendment to the existing licence agreement between Eden and Bayer Animal Health for animal health products was reported in May, for the purposes of progressing the final development of a portfolio of Bayer products based upon Eden's technology and know-how. This amendment involved an increased investment in the project, which was facilitated in part by Eden's successful capital raise in March. Bayer also completed the sale of its animal health business to Elanco, and the relevant agreements have now been transferred to Elanco." hxxps://polaris.brig | investingisatrickygame | |
13/8/2023 08:30 | Jeff Simmons .. President & CEO at Elanco Elanco’s second quarter results – exceeding expectations and delivering sequential improvement in underlying performance – reflect our global team’s deep commitment to our customers and the impact that reaching the world’s animals can have. Our Elanco team has been laser-focused on delivering value for customers and shareholders, and it showed in our results, exceeding the top end of the range for all targets and raising guidance for the year. We delivered a strong second quarter with continued sequential improvement in our underlying business, meaningful progress in our late-stage pipeline, and the successful completion of our ERP integration. Industry-leading, differentiated innovation will drive our long-term sustained growth and value. We are delivering new solutions to some of our customers’ greatest challenges from diabetes in cats and a treatment for deadly parvovirus in puppies to environmental solutions for livestock. And are making exciting progress on our next wave of differentiated innovation. Thank you to our customers – veterinarians, farmers, producers – what you do has never mattered more. Importantly, Elanco has reached an inflection point with our standup and integration now behind us. We’ve built an optimized infrastructure to deliver our next era of innovation, growth and value creation for customers and shareholders. It’s clear. Making life better for animals, makes life better. | supersonico | |
12/8/2023 21:56 | Rodney enjoys a good windfall Pitmaston Pineapple. | supersonico | |
12/8/2023 21:16 | Hey Liar, I notice you keep ignoring me! Post my IP Address as you claim to have it! | kittybiscuits | |
12/8/2023 20:51 | Ask again.. this time next year Rodney. | supersonico | |
12/8/2023 19:42 | What actually happened to Brooks Is he still around? | gemstar2 | |
11/8/2023 19:49 | Yes the relationship does indeed look solid (and strategic) as I thought it was with Sumiagro..what do I know.. but an arrangement could suit all parties and 10x revenues makes a deal hard to ignore. | supersonico | |
11/8/2023 19:21 | I think the sipcam relationship is strong - ie sipcam are doing a great job plus they continue to maintain their % interest whenever fund raises occur. | attyg | |
11/8/2023 18:16 | "This is the illustration I mentioned a little bit earlier where we're working with Corteva France to grow the overall addressable market for Eden's product by just changing the target by adding two new targets to the overall label , those targets are Downy Mildew and Powdery Mildew. Smith" @15.40m Slide 19 in above presentation or page 23 in Filling a gap in the Market. The key market in the first instance is France. Is the second key market USA where Mevalone registration has been stalled in California. Is the delay due to Downy Mildew and Powdery Mildew being rolled into the approval and will we see any change in the distributor from Sipcam to Corteva as we have seen in France where Corteva displaced Sumiagro ? AWGATWT. | supersonico | |
11/8/2023 17:44 | Dry chat as always Neuts. | timbo_slice | |
11/8/2023 17:16 | Hey Liar - thought you were going to post IP Addresses? | kittybiscuits | |
11/8/2023 13:01 | Miri about to go mad | jameschilds176 | |
11/8/2023 08:38 | Direction of travel...news 📍 July 12th was a memorable day, packed with emotions, as we have become Syngenta Biologicals, a brand that brings together Valagro’s legacy and Syngenta’s in-house biologicals business. As our Global Head Biologicals, Corey Huck, said “It’s a journey, filled with both opportunities and challenges. And the great news is our team is up for it, we are going to shape and lead the future of biologicals, globally”. | supersonico | |
11/8/2023 07:30 | Or a liar!!! Ie you. Now since you have my IP Address, post it. I give you permission | kittybiscuits | |
11/8/2023 00:11 | Or a Whale. | supersonico | |
10/8/2023 20:06 | Ask again.. this time next year Rodney. | supersonico | |
10/8/2023 19:49 | So, nearly a decade since Sir Ben triumphantly announced that the EU had approved Eden's lead product Has anything since then actually been successfully commercialised? | gemstar2 | |
10/8/2023 19:29 | What will you do without one? | alchemy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions